On May 14, 2024, MiNK Therapeutics, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9999 USD | +3.70% |
|
+0.50% | -6.55% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.55% | 37.96M | |
+47.60% | 57.87B | |
+41.48% | 40.25B | |
-7.04% | 39.94B | |
-5.96% | 28.54B | |
+11.83% | 26.4B | |
-20.16% | 19.33B | |
+30.24% | 12.4B | |
-0.84% | 12.23B | |
+24.23% | 12.2B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. announced that it has received $5.8 million in funding